Elite in Bladder Outlet Obstruction

Hann-chorng C. Kuo

707, Sec. 3, Chung Yang Rd, 970, 
Hualien City, TNQ, TW 
Elite in Bladder Outlet Obstruction
707, Sec. 3, Chung Yang Rd, 970, 
Hualien City, TNQ, TW 
OverviewLocationsClinical Research

Overview

Hann-chorng Kuo practices in Hualien City, Taiwan. Kuo is rated as an Elite expert by MediFind in the treatment of Bladder Outlet Obstruction. Their top areas of expertise are Urinary Incontinence, Interstitial Cystitis, Bladder Outlet Obstruction, Prostatectomy, and Endoscopy.

Their clinical research consists of co-authoring 392 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 73 articles in the study of Bladder Outlet Obstruction.

Locations

707, Sec. 3, Chung Yang Rd, 970, Hualien City, TNQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Radiogenomics in Aerodigestive Tract Cancers
Radiogenomics in Aerodigestive Tract Cancers
Enrollment Status: Completed
Publish Date: March 22, 2024
Intravesical Instillation of Liposome Encapsulated Botulinum Toxin A (Lipotoxin) in Treatment of Interstitial Cystitis - a Randomized, Double-blind, Placebo-controlled, Prospective Study
Intravesical Instillation of Liposome Encapsulated Botulinum Toxin A (Lipotoxin) in Treatment of Interstitial Cystitis - a Randomized, Double-blind, Placebo-controlled, Prospective Study
Enrollment Status: Completed
Publish Date: March 09, 2017
Intervention Type: Drug
Study Phase: Phase 2
Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome - A Prospective Randomized Controlled Comparative Study With Mono-antimuscarinic Therapy
Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome - A Prospective Randomized Controlled Comparative Study With Mono-antimuscarinic Therapy
Enrollment Status: Completed
Publish Date: March 08, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 2 Less Clinical Trials

392 Total Publications

Long-term clinical efficacy and cognitive impact of medications for overactive bladder related to the central nervous system.
Long-term clinical efficacy and cognitive impact of medications for overactive bladder related to the central nervous system.
Journal: International urology and nephrology
Published: August 31, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kuo's expertise for a condition
ConditionClose
View All 27 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile